UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050156
Receipt number R000057084
Scientific Title The research for patients scheduled for cataract surgery with blepharitis
Date of disclosure of the study information 2023/01/27
Last modified on 2023/01/23 14:45:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The research for patients scheduled for cataract surgery with blepharitis

Acronym

The research for posterior blepharitis

Scientific Title

The research for patients scheduled for cataract surgery with blepharitis

Scientific Title:Acronym

The research for posterior blepharitis

Region

Japan


Condition

Condition

blepharitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate not only the prevalence of blepharitis but also the actual treatment status and efficacy for posterior blepharitis in patients scheduled for cataract surgery.

Basic objectives2

Others

Basic objectives -Others

To investigate not only the prevalence of blepharitis but also the actual treatment status and efficacy for posterior blepharitis in patients scheduled for cataract surgery.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Score changes in objective and subjective findings 4 weeks after treatment for posterior blepharitis

Key secondary outcomes

The prevalence of blepharitis
The bacteriological evaluation of meibum


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Blepharitis prevalence research
Those scheduled to undergo cataract surgery
Outpatient over 60 years old

2. Posterior blepharitis treatment research
Those who have obtained written consent of the research
Subjects with blepharitis, especially posterior blepharitis alone

Key exclusion criteria

None.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Kinoshita

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Frontier Medical Science and Technology for Ophthalmology

Zip code

602-0841

Address

450 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, Kyoto

TEL

+81(75)251-5772

Email

shigeruk@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Kojiro
Middle name
Last name Imai

Organization

Kyoto Prefectural University of Medicine

Division name

Department for Medical Innovation and Translational Medical Science

Zip code

602-0841

Address

465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, Kyoto

TEL

+81(75)251-5308

Homepage URL


Email

kimai@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

SENJU PHARMACEUTICAL CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Kyoto Prefectural University of Medicine

Address

465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, Kyoto

Tel

+81(75)251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都府立医科大学附属病院(京都府)、京都市立病院(京都府)、バプテスト眼科クリニック(京都府)


Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 09 Month 26 Day

Date of IRB

2022 Year 10 Month 13 Day

Anticipated trial start date

2023 Year 01 Month 27 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

At first, we research the prevalence of blepharitis in 200 patients scheduled for cataract surgery. Next, we research the treatment status and efficacy of posterior blepharitis before cataract surgery in 50 patients scheduled for cataract surgery who were diagnosed with posterior blepharitis alone and judged to need antibiotics.


Management information

Registered date

2023 Year 01 Month 27 Day

Last modified on

2023 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057084


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name